Parker Institute for Cancer Immunotherapy Hires Verily Communications Chief to Lead Messaging
Event summary
- Parker Institute for Cancer Immunotherapy (PICI) appointed Bob Purcell as Chief Communications Officer on February 25, 2026.
- Purcell brings 25 years of experience in biotech and healthcare communications, most recently as Head of Communications at Verily.
- PICI aims to leverage Purcell's expertise to expand awareness of its cancer immunotherapy research and partnerships.
- PICI has supported over 1,000 investigators and has a portfolio of 17 biotech ventures with over $4B raised in capital.
The big picture
Purcell's appointment comes as PICI enters its 10th year, aiming to turn all cancers into curable diseases through collaborative research. His background in biotech and healthcare communications positions him to drive strategic storytelling and thought leadership, crucial for PICI's mission to bridge scientific discovery and patient access. The move reflects a broader industry trend of nonprofits leveraging corporate communications expertise to amplify their impact.
What we're watching
- Messaging Effectiveness
- How Purcell's strategic communications will enhance PICI's ability to attract partners and investors.
- Stakeholder Engagement
- Whether Purcell can strengthen PICI's reach across diverse communities and improve patient outcomes.
- Scientific Impact
- The pace at which PICI can translate its research into commercialized therapies under Purcell's leadership.
Related topics